Itraconazole inhaled (Pulmatrix)

伊曲康唑吸入式干粉制剂

Report date: 2024/03/28 13:04:35

Base Information

Drug NameItraconazole inhaled (Pulmatrix)
Drug Alias NameItraconazolum (Pulmatrix)Itraconazole PowderPulmazolePUR-1900
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsAsthmaAspergillosis, Allergic Bronchopulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandAustralia +[6
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPulmatrix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmatrix IncCipla Ltd
Active IndicationsN/A
Inactive IndicationsAsthmaAspergillosis, Allergic Bronchopulmonary

Other Information

ATC CodeJ02AC02